Evaluating Home Testing Devices for the Management of Glaucoma

Description

With the advancement in technology we have the opportunity of performing the glaucoma testing at home to monitor the disease. The purpose of this study is evaluating the feasibility and patient acceptance of home testing with head mounted perimetry; detection of progression with head mounted perimetry vs office based perimetry; and monitoring the eye pressure measured by patients at home using a portable tonometer.

Conditions

Glaucoma, Open-Angle

Talk to us

Study Overview

On this page

Study Details

Study overview

With the advancement in technology we have the opportunity of performing the glaucoma testing at home to monitor the disease. The purpose of this study is evaluating the feasibility and patient acceptance of home testing with head mounted perimetry; detection of progression with head mounted perimetry vs office based perimetry; and monitoring the eye pressure measured by patients at home using a portable tonometer.

Evaluating Effectiveness of Home Testing Devises for Assisting in Management of Glaucoma Outside a Clinical Setting During a 2 Year Period.

Evaluating Home Testing Devices for the Management of Glaucoma

Condition
Glaucoma, Open-Angle
Intervention / Treatment

-

Contacts and Locations

Philadelphia

Wills Eye Hospital, Philadelphia, Pennsylvania, United States, 19107

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Age 20-80 years
  • 2. Mild and Moderate Open Angle Glaucoma (OAG)
  • 3. Refraction under 12.00 diopter of spherical refractive error and astigmatism of less than 2.5 diopter.
  • 1. Spherical refraction outside \> ± 12.00 D and cylinder correction \> +2.5 D.
  • 2. Visual acuity worse than 20/50 either eye
  • 3. Cataract surgery with or without Minimally Invasive Glaucoma Surgery (MIGS) less than 90 days prior to enrollment
  • 4. Filtering surgeries less than 6 months prior to enrollment
  • 5. Intraocular surgery other than:
  • 1. Non-complicated MIGS more than 90 days prior to enrollment;
  • 2. Cataract or refractive surgery performed more than 90 days before enrollment and without posterior capsule opacification
  • 3. Other glaucoma surgery more than 6 months prior to enrollment.
  • 6. History of systemic or ocular condition (other than glaucoma or mild to moderate cataract) known to affect visual function.
  • 7. History of medication known to affect visual function or influence patient reaction time
  • 8. Inability to use device after remote training session
  • 9. Subjects unwilling and/or unable to participate

Ages Eligible for Study

20 Years to 80 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Wills Eye,

M. Reza Razeghinejad, MD, PRINCIPAL_INVESTIGATOR, Wills Eye Hospital

Study Record Dates

2026-12-31